The European Union, France, and Nigeria have signed a €10.2 million pact to boost local medication production, enhancing Nigerias health system and pharmaceutical manufacturing capacity.
- On Sunday, the Federal Government of Nigeria signed a €10.2 million partnership agreement with the European Union and France to improve local medication production.
- The initiative, part of the Global Gateways Manufacturing and Access to Vaccines, Medicines, and Health Technologies Initiative, aims to strengthen Nigerias health system and manufacturing capabilities.
- Named the Quality Uplift for Advancing Local Industry in Medicine Standards, the project will enhance Nigerias pharmaceutical ecosystem and ensure better access to quality medications.
Why It Matters
This partnership underscores a significant investment in Nigerias health infrastructure, aiming to reduce dependency on imported medications and improve vaccine access, thus enhancing public health resilience in the region.